ASMB - Company ID 0001426800
The table below shows ASSEMBLY BIOSCIENCES, INC.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$22.10M | -$23.44M | -$18.36M | -$23.43M | -$27.50M | -$33.34M |
| Capital expenditure | $19.00K | $0.00 | $14.00K | $0.00 | $0.00 | $3.08M |
| Investing cash flow | -$5.38M | $6.59M | $17.27M | $10.00M | $33.05M | $18.02M |
| Dividends paid | - | - | - | - |
ASSEMBLY BIOSCIENCES, INC. reported operating cash flow of -$41.09M for fiscal year 2025. That is up 19.6% from -$51.12M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$34.88M (FY 2016) to -$41.09M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $149.00K | $1.92M | $0.00 | $4.49M | $0.00 | $34.14M |